Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.

Identifieur interne : 001C33 ( Main/Exploration ); précédent : 001C32; suivant : 001C34

Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.

Auteurs : Maria H. J Ntti [Finlande] ; Ilona Mandrika [Lettonie] ; Jyrki P. Kukkonen [Finlande]

Source :

RBID : pubmed:24530395

Descripteurs français

English descriptors

Abstract

Human OX1 orexin receptors have been shown to homodimerize and they have also been suggested to heterodimerize with CB1 cannabinoid receptors. The latter has been suggested to be important for orexin receptor responses and trafficking. In this study, we wanted to assess the ability of the other combinations of receptors to also form similar complexes. Vectors for expression of human OX1, OX2 and CB1 receptors, C-terminally fused with either Renilla luciferase or GFP(2) green fluorescent protein variant, were generated. The constructs were transiently expressed in Chinese hamster ovary cells, and constitutive dimerization between the receptors was assessed by bioluminescence energy transfer (BRET). Orexin receptor subtypes readily formed homo- and hetero(di)mers, as suggested by significant BRET signals. CB1 receptors formed homodimers, and they also heterodimerized with both orexin receptors. Interestingly, BRET efficiency was higher for homodimers than for almost all heterodimers. This is likely to be due to the geometry of the interaction; the putatively symmetric dimers may place the C-termini in a more suitable orientation in homomers. Fusion of luciferase to an orexin receptor and GFP(2) to CB1 produced more effective BRET than the opposite fusions, also suggesting differences in geometry. Similar was seen for the OX1-OX2 interaction. In conclusion, orexin receptors have a significant propensity to make homo- and heterodi-/oligomeric complexes. However, it is unclear whether this affects their signaling. As orexin receptors efficiently signal via endocannabinoid production to CB1 receptors, dimerization could be an effective way of forming signal complexes with optimal cannabinoid concentrations available for cannabinoid receptors.

DOI: 10.1016/j.bbrc.2014.02.026
PubMed: 24530395


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.</title>
<author>
<name sortKey="J Ntti, Maria H" sort="J Ntti, Maria H" uniqKey="J Ntti M" first="Maria H" last="J Ntti">Maria H. J Ntti</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Veterinary Biosciences, POB 66, FIN-00014 University of Helsinki, Finland. Electronic address: maria.jantti@helsinki.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Veterinary Biosciences, POB 66, FIN-00014 University of Helsinki</wicri:regionArea>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mandrika, Ilona" sort="Mandrika, Ilona" uniqKey="Mandrika I" first="Ilona" last="Mandrika">Ilona Mandrika</name>
<affiliation wicri:level="1">
<nlm:affiliation>Latvian Biomedical Research and Study Centre, Ratsupites Str. 1, Riga LV 1067, Latvia. Electronic address: ilona@biomed.lu.lv.</nlm:affiliation>
<country xml:lang="fr">Lettonie</country>
<wicri:regionArea>Latvian Biomedical Research and Study Centre, Ratsupites Str. 1, Riga LV 1067</wicri:regionArea>
<wicri:noRegion>Riga LV 1067</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kukkonen, Jyrki P" sort="Kukkonen, Jyrki P" uniqKey="Kukkonen J" first="Jyrki P" last="Kukkonen">Jyrki P. Kukkonen</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Veterinary Biosciences, POB 66, FIN-00014 University of Helsinki, Finland. Electronic address: jyrki.kukkonen@helsinki.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Veterinary Biosciences, POB 66, FIN-00014 University of Helsinki</wicri:regionArea>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24530395</idno>
<idno type="pmid">24530395</idno>
<idno type="doi">10.1016/j.bbrc.2014.02.026</idno>
<idno type="wicri:Area/PubMed/Corpus">001A56</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A56</idno>
<idno type="wicri:Area/PubMed/Curation">001A56</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A56</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001887</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001887</idno>
<idno type="wicri:Area/Ncbi/Merge">000C88</idno>
<idno type="wicri:Area/Ncbi/Curation">000C88</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C88</idno>
<idno type="wicri:Area/Main/Merge">001C46</idno>
<idno type="wicri:Area/Main/Curation">001C33</idno>
<idno type="wicri:Area/Main/Exploration">001C33</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.</title>
<author>
<name sortKey="J Ntti, Maria H" sort="J Ntti, Maria H" uniqKey="J Ntti M" first="Maria H" last="J Ntti">Maria H. J Ntti</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Veterinary Biosciences, POB 66, FIN-00014 University of Helsinki, Finland. Electronic address: maria.jantti@helsinki.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Veterinary Biosciences, POB 66, FIN-00014 University of Helsinki</wicri:regionArea>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mandrika, Ilona" sort="Mandrika, Ilona" uniqKey="Mandrika I" first="Ilona" last="Mandrika">Ilona Mandrika</name>
<affiliation wicri:level="1">
<nlm:affiliation>Latvian Biomedical Research and Study Centre, Ratsupites Str. 1, Riga LV 1067, Latvia. Electronic address: ilona@biomed.lu.lv.</nlm:affiliation>
<country xml:lang="fr">Lettonie</country>
<wicri:regionArea>Latvian Biomedical Research and Study Centre, Ratsupites Str. 1, Riga LV 1067</wicri:regionArea>
<wicri:noRegion>Riga LV 1067</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kukkonen, Jyrki P" sort="Kukkonen, Jyrki P" uniqKey="Kukkonen J" first="Jyrki P" last="Kukkonen">Jyrki P. Kukkonen</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Veterinary Biosciences, POB 66, FIN-00014 University of Helsinki, Finland. Electronic address: jyrki.kukkonen@helsinki.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Veterinary Biosciences, POB 66, FIN-00014 University of Helsinki</wicri:regionArea>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Biochemical and biophysical research communications</title>
<idno type="eISSN">1090-2104</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>CHO Cells</term>
<term>Cricetinae</term>
<term>Cricetulus</term>
<term>Humans</term>
<term>Luminescent Measurements</term>
<term>Orexin Receptors (chemistry)</term>
<term>Orexin Receptors (metabolism)</term>
<term>Protein Multimerization</term>
<term>Receptor, Cannabinoid, CB1 (chemistry)</term>
<term>Receptor, Cannabinoid, CB1 (metabolism)</term>
<term>Recombinant Fusion Proteins (chemistry)</term>
<term>Recombinant Fusion Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules CHO</term>
<term>Cricetinae</term>
<term>Cricetulus</term>
<term>Humains</term>
<term>Mesures de luminescence</term>
<term>Multimérisation de protéines</term>
<term>Protéines de fusion recombinantes ()</term>
<term>Protéines de fusion recombinantes (métabolisme)</term>
<term>Récepteur cannabinoïde de type CB1 ()</term>
<term>Récepteur cannabinoïde de type CB1 (métabolisme)</term>
<term>Récepteurs des orexines ()</term>
<term>Récepteurs des orexines (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Orexin Receptors</term>
<term>Receptor, Cannabinoid, CB1</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Orexin Receptors</term>
<term>Receptor, Cannabinoid, CB1</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Protéines de fusion recombinantes</term>
<term>Récepteur cannabinoïde de type CB1</term>
<term>Récepteurs des orexines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>CHO Cells</term>
<term>Cricetinae</term>
<term>Cricetulus</term>
<term>Humans</term>
<term>Luminescent Measurements</term>
<term>Protein Multimerization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules CHO</term>
<term>Cricetinae</term>
<term>Cricetulus</term>
<term>Humains</term>
<term>Mesures de luminescence</term>
<term>Multimérisation de protéines</term>
<term>Protéines de fusion recombinantes</term>
<term>Récepteur cannabinoïde de type CB1</term>
<term>Récepteurs des orexines</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Human OX1 orexin receptors have been shown to homodimerize and they have also been suggested to heterodimerize with CB1 cannabinoid receptors. The latter has been suggested to be important for orexin receptor responses and trafficking. In this study, we wanted to assess the ability of the other combinations of receptors to also form similar complexes. Vectors for expression of human OX1, OX2 and CB1 receptors, C-terminally fused with either Renilla luciferase or GFP(2) green fluorescent protein variant, were generated. The constructs were transiently expressed in Chinese hamster ovary cells, and constitutive dimerization between the receptors was assessed by bioluminescence energy transfer (BRET). Orexin receptor subtypes readily formed homo- and hetero(di)mers, as suggested by significant BRET signals. CB1 receptors formed homodimers, and they also heterodimerized with both orexin receptors. Interestingly, BRET efficiency was higher for homodimers than for almost all heterodimers. This is likely to be due to the geometry of the interaction; the putatively symmetric dimers may place the C-termini in a more suitable orientation in homomers. Fusion of luciferase to an orexin receptor and GFP(2) to CB1 produced more effective BRET than the opposite fusions, also suggesting differences in geometry. Similar was seen for the OX1-OX2 interaction. In conclusion, orexin receptors have a significant propensity to make homo- and heterodi-/oligomeric complexes. However, it is unclear whether this affects their signaling. As orexin receptors efficiently signal via endocannabinoid production to CB1 receptors, dimerization could be an effective way of forming signal complexes with optimal cannabinoid concentrations available for cannabinoid receptors. </div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Finlande</li>
<li>Lettonie</li>
</country>
<region>
<li>Uusimaa</li>
</region>
<settlement>
<li>Helsinki</li>
</settlement>
<orgName>
<li>Université d'Helsinki</li>
</orgName>
</list>
<tree>
<country name="Finlande">
<region name="Uusimaa">
<name sortKey="J Ntti, Maria H" sort="J Ntti, Maria H" uniqKey="J Ntti M" first="Maria H" last="J Ntti">Maria H. J Ntti</name>
</region>
<name sortKey="Kukkonen, Jyrki P" sort="Kukkonen, Jyrki P" uniqKey="Kukkonen J" first="Jyrki P" last="Kukkonen">Jyrki P. Kukkonen</name>
</country>
<country name="Lettonie">
<noRegion>
<name sortKey="Mandrika, Ilona" sort="Mandrika, Ilona" uniqKey="Mandrika I" first="Ilona" last="Mandrika">Ilona Mandrika</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C33 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C33 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24530395
   |texte=   Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24530395" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021